A document prepared for the FDA Advisory Committee meeting, in which members voted seventeen to zero in favour of giving emergency use authorisation for the administration of the Pfizer Covid-19 injection to children aged 5 to 11, confirms that Pfizer have modified the formulation of their injection for children to include an ingredient that reduces the acidity of blood and is used to stabilise people who have suffered a heart attack. Source – Page 14By Patricia HarrityThe FDA Briefing Document titled ‘EUA amendment request for Pfizer-BioNTech COVID-19 Vaccine for use in children 5 though 11 years of age‘ states the...